OGT Complements Chromosomal Microarray Portfolio with Acquisition of FISH Probe Firm Cytocell | GenomeWeb

Oxford Gene Technology this week announced that it has acquired Cytocell, a supplier of probes for fluorescence in situ hybridization experiments.

OGT CEO Mike Evans told BioArray News that the deal will enable the Oxford, UK-based company to sell more products to customers that use its chromosomal microarrays, as well as to develop new FISH probes based on array findings.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.